NCT05619367 2025-12-23A Compassionate Use (CU) Program of OdronextamabRegeneron PharmaceuticalsAvailable
NCT02715843 2019-10-11Extended Treatment Access Study of MT-3724 for Subjects With Relapsed Non-Hodgkin's B-Cell LymphomaMolecular Templates, Inc.No longer available